How to Shatter Validation Barriers With Intelligent Agents to Enable Intelligent Batch Records
Time
5:30 PM – 7:00 PM, Central European Time (CET)
11:30 AM – 1:00 PM, Eastern Time (ET)
Overview
Validation remains one of the most critical and time-intensive aspects of pharmaceutical manufacturing digitization—especially when transitioning from paper-based documentation to fully digital batch records and recipes. As a cornerstone of quality and compliance, validation demands significant attention, yet traditional approaches often struggle to keep pace with the speed and complexity of modern operations.
Intelligent agents are a type of artificial intelligence system that can make decisions and take actions autonomously, with minimal human intervention. In pharmaceutical settings, these systems are designed to analyze context, assess risk, and provide recommendations—while leaving the final decision in the hands of subject matter experts. When applied thoughtfully in regulated environments, intelligent agents reduce manual workload, improve consistency, and embed intelligence into processes that were previously static or reactive.
In this webinar, you’ll learn how Aizon is leveraging its Intelligent Agents to transform digital validation and execution readiness. The result is the Intelligent Batch Record (iBR)—a new class of batch record with built-in compliance capabilities that enable faster go-lives, seamless recipe conversion from paper to digital, augmented workflow creation, and continuous system and MBR validation.
Join us to explore how pharma manufacturers can turn validation into a strategic advantage—eliminating delays and unlocking the full potential of digital execution.
Speakers
-
Geri StudebakerChief Commercial Officer at AizonGeri Studebaker, Chief Commercial Officer at Aizon, is a transformational leader dedicated to enhancing global health through innovative business strategies. With a rich background that includes pivotal roles at Google, Geri has been instrumental in driving digital transformation and fostering strategic partnerships. At Aizon, she is redefining how the pharmaceutical industry leverages AI to drive business outcomes, leading efforts to accelerate the digital transformation of pharma manufacturing, optimizing efficiency, increasing yield and quality.
-
Toni ManzanoCo-founder and Chief Science Officer of AizonToni Manzano is a co-founder and Chief Science Officer of Aizon, bringing over two decades of experience in leading software projects for international pharmaceutical companies, with a focus on manufacturing and supply chain optimization.
Trained as an astrophysicist, Toni has become a recognized expert in Quality and Artificial Intelligence in the pharmaceutical sector, sharing his expertise as a lecturer at several universities. A prolific scientific writer, he holds a dozen international patents and is a member of the PDA Regulatory Affairs & Quality Advisory Board. Toni also actively contributes to the United Nations’ AI initiative.
Partner
Aizon
Website
http://www.aizon.aiAizon pioneers Intelligent GxP Manufacturing: eliminate paper, boost yield, cut deviations, and ensure quality with AI, in just a few weeks.
-
Who Should Attend
- Pharma manufacturing (pharma/biopharma/cdmo/cmo)
- Quality
- Process
- Digital
- AI / Data Science - Skill Level Novice
-
Topics
- Clarity on the evolving role of validation in pharmaceutical digitization and how to navigate it more efficiently
- A clear understanding of Intelligent Agents and their real-world application in supporting validation, compliance, and execution readiness
- An introduction to Intelligent Batch Records (iBR) and how they differ from traditional eBR or paper-on-glass systems
- Actionable insights on accelerating go-lives, converting paper recipes, and building compliant digital workflows
- Strategies for continuous validation that reduce audit risk and remove delays from deployment cycles
- Examples and use cases from leading pharmaceutical companies embracing this shift -
Special event information
All participants will get a complimentary certificate of attendance courtesy of the webinar's partner - Aizon.
Time
5:30 PM – 7:00 PM, Central European Time (CET)
11:30 AM – 1:00 PM, Eastern Time (ET)
Speakers
-
Geri StudebakerChief Commercial Officer at Aizon
Geri Studebaker, Chief Commercial Officer at Aizon, is a transformational leader dedicated to enhancing global health through innovative business strategies. With a rich background that includes pivotal roles at Google, Geri has been instrumental in driving digital transformation and fostering strategic partnerships. At Aizon, she is redefining how the pharmaceutical industry leverages AI to drive business outcomes, leading efforts to accelerate the digital transformation of pharma manufacturing, optimizing efficiency, increasing yield and quality.
-
Toni ManzanoCo-founder and Chief Science Officer of Aizon
Toni Manzano is a co-founder and Chief Science Officer of Aizon, bringing over two decades of experience in leading software projects for international pharmaceutical companies, with a focus on manufacturing and supply chain optimization.
Trained as an astrophysicist, Toni has become a recognized expert in Quality and Artificial Intelligence in the pharmaceutical sector, sharing his expertise as a lecturer at several universities. A prolific scientific writer, he holds a dozen international patents and is a member of the PDA Regulatory Affairs & Quality Advisory Board. Toni also actively contributes to the United Nations’ AI initiative.
Partner
Aizon
Website
http://www.aizon.aiAizon pioneers Intelligent GxP Manufacturing: eliminate paper, boost yield, cut deviations, and ensure quality with AI, in just a few weeks.
What people are saying
Related Events
